{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:26:14Z","timestamp":1777375574846,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1006\/clim.1999.4830","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T19:13:49Z","timestamp":1033931629000},"page":"173-178","source":"Crossref","is-referenced-by-count":37,"title":["Human Mast Cells Express the Hyaluronic-Acid-Binding Isoform of CD44 and Adhere to Hyaluronic Acid"],"prefix":"10.1006","volume":"94","author":[{"given":"Mieko","family":"Fukui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Whittlesey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean D.","family":"Metcalfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Dastych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clim.1999.4830_RF1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0092-8674(90)90694-A","article-title":"CD44 is the principal cell surface receptor for hyaluronate","volume":"61","author":"Aruffo","year":"1990","journal-title":"Cell"},{"key":"10.1006\/clim.1999.4830_RF2","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.4049\/jimmunol.151.12.6634","article-title":"Hyaluronic acid-induced signal transduction and HA receptor (GP85\/CD44)\u2014Cytoskeleton interaction","volume":"151","author":"Bourguignon","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4830_RF3","first-page":"347","article-title":"The transmembrane hyaluronate receptor (CD44): Multiple functions, multiple forms","volume":"3","author":"Haynes","year":"1991","journal-title":"Cancer Cells"},{"key":"10.1006\/clim.1999.4830_RF4","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/S0022-5347(01)62613-2","article-title":"Interaction between CD44 and hyaluronic acid regulates human prostate cancer development","volume":"160","author":"Miyake","year":"1998","journal-title":"J. Urol."},{"key":"10.1006\/clim.1999.4830_RF5","first-page":"87","article-title":"A new cell adhesion mechanism involving hyaluronate and CD44","volume":"166","author":"Miyake","year":"1990","journal-title":"Curr. Topics Microbiol. Immunol."},{"key":"10.1006\/clim.1999.4830_RF6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0092-8674(91)90403-L","article-title":"A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells","volume":"65","author":"Gunthert","year":"1991","journal-title":"Cell"},{"key":"10.1006\/clim.1999.4830_RF7","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1083\/jcb.105.2.983","article-title":"Lymphocyte recognition of high endothelium: Antibodies to distinct epitopes of an 85\u201395-kd glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells","volume":"105","author":"Jalkanen","year":"1987","journal-title":"J. Cell Biol."},{"key":"10.1006\/clim.1999.4830_RF8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1084\/jem.180.1.53","article-title":"Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development","volume":"180","author":"Bartolazzi","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.1999.4830_RF9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2567.1998.00431.x","article-title":"Forms and functions of CD44","volume":"93","author":"Borland","year":"1998","journal-title":"Immunology"},{"key":"10.1006\/clim.1999.4830_RF10","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.1496383","article-title":"Participation in normal immune responses of a metastasis-inducing splice variant of CD44","volume":"257","author":"Arch","year":"1992","journal-title":"Science"},{"key":"10.1006\/clim.1999.4830_RF11","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1002\/eji.1830251033","article-title":"Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells","volume":"25","author":"Galluzzo","year":"1995","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clim.1999.4830_RF12","doi-asserted-by":"crossref","first-page":"D604","DOI":"10.2741\/A305","article-title":"The role of CD44 as a cell surface hyaluronan receptor during tumor invasion of connective tissue","volume":"3","author":"Knudson","year":"1998","journal-title":"Frontiers Biosci."},{"key":"10.1006\/clim.1999.4830_RF13","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.4049\/jimmunol.158.6.3000","article-title":"Origin and function of circulating CD44 in non-Hodgkin's lymphoma","volume":"158","author":"Ristamaki","year":"1997","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4830_RF14","first-page":"426","article-title":"Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer","volume":"54","author":"Guo","year":"1994","journal-title":"Cancer Res."},{"key":"10.1006\/clim.1999.4830_RF15","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.leu.2400525","article-title":"Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic leukemia","volume":"11","author":"De Rossi","year":"1997","journal-title":"Leukemia"},{"key":"10.1006\/clim.1999.4830_RF16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/BF01330293","article-title":"Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis","volume":"16","author":"Kittl","year":"1997","journal-title":"Rheumatol. Int."},{"key":"10.1006\/clim.1999.4830_RF17","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/1523-1747.ep12343953","article-title":"Interactions of immature human mast cells with extracellular matrix: Expression of specific adhesion receptors and their role in cell binding to matrix proteins","volume":"106","author":"Kruger-Krasagakes","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/clim.1999.4830_RF18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1046\/j.1523-1747.1998.00359.x","article-title":"Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies","volume":"111","author":"Ghannadan","year":"1998","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/clim.1999.4830_RF19","first-page":"158","article-title":"Phenotypic and functional characterization of mast cells derived from renal tumor tissues","volume":"26","author":"Beil","year":"1998","journal-title":"Exp. Hematol."},{"key":"10.1006\/clim.1999.4830_RF20","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1182\/blood.V84.11.3876.bloodjournal84113876","article-title":"The human cardiac mast cell: Localization, isolation, phenotype, and functional characterization","volume":"84","author":"Sperr","year":"1994","journal-title":"Blood"},{"key":"10.1006\/clim.1999.4830_RF21","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/jlb.61.5.592","article-title":"Immunophenotypic and functional characterization of human tonsillar mast cells","volume":"61","author":"Fureder","year":"1997","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clim.1999.4830_RF22","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1155\/1998\/341340","article-title":"Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of mormal and pathological bone marrow samples","volume":"16","author":"Escribano","year":"1998","journal-title":"Anal. Cell. Pathol."},{"key":"10.1006\/clim.1999.4830_RF23","first-page":"245","article-title":"Inhibition of human mast cell growth and differentiation by interferon gamma-1\u03b2","volume":"26","author":"Kirshenbaun","year":"1998","journal-title":"Exp. Hematol."},{"key":"10.1006\/clim.1999.4830_RF24","first-page":"343","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"4","author":"Butterfield","year":"1988","journal-title":"Leukocyte Res."},{"key":"10.1006\/clim.1999.4830_RF25","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1111\/1523-1747.ep12468882","article-title":"Classification and diagnosis of mastocytosis: current status","volume":"96","author":"Metcalfe","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1006\/clim.1999.4830_RF26","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF01533368","article-title":"Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis","volume":"14","author":"Schwartz","year":"1994","journal-title":"J. Clin. Immunol."},{"key":"10.1006\/clim.1999.4830_RF27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/0014-4827(90)90085-O","article-title":"Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1","volume":"187","author":"Lesley","year":"1990","journal-title":"Exp. Cell Res."},{"key":"10.1006\/clim.1999.4830_RF28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1182\/blood.V86.3.930.930","article-title":"Human mast cells derived from fetal liver cells cultured with stem cell factor express a functional CD51\/CD61 (alpha v beta 3) integrin","volume":"86","author":"Shimizu","year":"1995","journal-title":"Blood"},{"key":"10.1006\/clim.1999.4830_RF29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00123391","article-title":"Human ovarian tumor cells can bind hyaluronic acid via membrane CD44: A possible step in peritoneal metastasis","volume":"14","author":"Gardner","year":"1996","journal-title":"Clin. Exp. Metast."},{"key":"10.1006\/clim.1999.4830_RF30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/j.1460-2075.1991.tb07955.x","article-title":"The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells","volume":"10","author":"Stamenkovic","year":"1991","journal-title":"EMBO J."},{"key":"10.1006\/clim.1999.4830_RF31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/(SICI)1096-9896(199803)184:3<291::AID-PATH1>3.0.CO;2-O","article-title":"Hyaluronate binding assay study of transfected CD44 v4-v7 isoforms into the human gastric carcinoma cell lline SC-M1","volume":"184","author":"Harn","year":"1998","journal-title":"J. Pathol."},{"key":"10.1006\/clim.1999.4830_RF32","first-page":"1519","article-title":"Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms","volume":"149","author":"Woodman","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1006\/clim.1999.4830_RF33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00200656","article-title":"Expression of CD44 splice variants in human skin and epidurmal tumors","volume":"428","author":"Seiter","year":"1996","journal-title":"Virchows Arch."},{"key":"10.1006\/clim.1999.4830_RF34","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1002\/eji.1830211222","article-title":"Down-regulation by tumor necrosis factor-alpha of neutrophil cell surface expression of the sialophorin CD43 and the hyaluronate receptor CD44 through a proteolytic mechanism","volume":"21","author":"Campanero","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clim.1999.4830_RF35","first-page":"3045","article-title":"Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes","volume":"21","author":"Bazil","year":"1991","journal-title":"J. Immunol."},{"key":"10.1006\/clim.1999.4830_RF36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1023\/A:1005913514376","article-title":"Soluble CD44 v5 and v6 in serum of patients with breast cancer. Correlation with expression of CD44 v5 and v6 variants in primary tumors and location of distant metastasis","volume":"47","author":"Lackner","year":"1998","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661699948301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661699948301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T16:21:46Z","timestamp":1680625306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661699948301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["S1521661699948301"],"URL":"https:\/\/doi.org\/10.1006\/clim.1999.4830","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}